Novel dosage form

Details for Australian Patent Application No. 2008220795 (hide)

Owner Glaxo Group Limited

Inventors Li, Yu; Cullingford, David Geoffrey; Clarke, Allan James

Agent Davies Collison Cave

Pub. Number AU-A-2008220795

PCT Pub. Number WO2008/104590

Priority 60/892,267 01.03.07 US

Filing date 28 February 2008

Wipo publication date 4 September 2008

International Classifications

A61K 9/20 (2006.01) Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 9/50 (2006.01) Medicinal preparations characterised by special physical form - Microcapsules

A61K 31/55 (2006.01) - having seven-membered rings, e.g. azelastine, pentylenetetrazole

Event Publications

17 September 2009 PCT application entered the National Phase

  PCT publication WO2008/104590 Priority application(s): WO2008/104590

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008220800-Acid addition salts, hydrates and polymorphs of 5-(2,4-dihydroxy-5-isopropyl-phenyl)-4-( 4-morpholin-4-ylmethyl-phenyl)-isoxazo le-3-carboxylic acid ethylamide and formulations comprising these forms

2008220794-Novel dosage form